1. Decreased interleukin(IL)-35 Expression is Associated with Active Intraocular Inflammation in Vogt-Koyanagi-Harada (VKH) Disease
   Jianping Hu et al, 2019, Ocular Immunology and Inflammation CrossRef
2. Serum level of interleukin‐35 as a potential prognostic factor for gastric cancer
   Jin‐Hua Gu et al, 2021, Asia-Pacific Journal of Clinical Oncology CrossRef
3. IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment
   Pengcheng Yi et al, 2024, Molecular Cancer Therapeutics CrossRef
4. The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
   Yuqiu Hao et al, 2022, Frontiers in Oncology CrossRef
5. Elevated Plasma Interleukin-35 as a Prognostic Indicator in Localized Clear Cell Renal Cell Carcinoma
   Jun Zhang et al, 2022, Evidence-Based Complementary and Alternative Medicine CrossRef
6. Current Insight into the Role of IL-35 and Its Potential Involvement in the Pathogenesis and Therapy of Atopic Dermatitis
   Weronika Zysk et al, 2022, International Journal of Molecular Sciences CrossRef
7. Interleukin-35 promotes progression of prostate cancer and inhibits anti-tumour immunity
   Jialin Zhu et al, 2020, Cancer Cell International CrossRef
8. Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer
   Nazanin Chatrabnous et al, 2019, Cytokine CrossRef
9. Interleukin‑35 is associated with the tumorigenesis and progression of prostate cancer
   Jialin Zhu et al, 2019, Oncology Letters CrossRef